Impact of UGT1A1 gilbert variant on discontinuation of ritonavir-boosted atazanavir in AIDS clinical trials group study A5202

Heather J. Ribaudo, Eric S. Daar, Camlin Tierney, Gene D. Morse, Katie Mollan, Paul E. Sax, Margaret A. Fischl, Ann C. Collier, David W. Haas

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Fingerprint Dive into the research topics of 'Impact of UGT1A1 gilbert variant on discontinuation of ritonavir-boosted atazanavir in AIDS clinical trials group study A5202'. Together they form a unique fingerprint.

Medicine & Life Sciences